Tetanus Vaccine
Tetanus and TBE vaccines do not protect healthy elderly adults
Published in Vaccine Weekly, July 27th, 2005
According to recent research from Austria, "Little information is available on post-vaccination antibody concentrations and the duration of protection in persons of more than 20 years of age. Therefore, we measured antibodies specific for tetanus (TT) or tick-borne encephalitis (TBE) virus in 734 adults (age 18-93 years, 382 females and 352 males) and evaluated these data in connection with the time point of the last vaccination against tetanus or TBE and age.
"This analysis revealed that the time of the last vaccination as well as age had highly significant effects...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-07-27)
More Articles from Vaccine Weekly
- Allergy Medicine
Molecule resembling grass pollen epitopes developed for allergy vaccine - Herpes Zoster Vaccine
Vaccine to prevent herpes zoster and postherpetic neuralgia developed - Melanoma Vaccine
Noncanonical melanoma T cell epitopes identified for cancer therapy - Meningitis Vaccine
Meningococcal epidemiology changed after bivalent vaccine introduced - Tuberculosis Vaccine
Ag85B fusion molecule-based tuberculosis subunit vaccine developed - Adriamycin Nephropathy
Naked DNA encoding MCP-1 and RANTES protects against renal injury - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
